These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 14707449)

  • 61. Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma.
    Witzig TE; White CA; Wiseman GA; Gordon LI; Emmanouilides C; Raubitschek A; Janakiraman N; Gutheil J; Schilder RJ; Spies S; Silverman DH; Parker E; Grillo-López AJ
    J Clin Oncol; 1999 Dec; 17(12):3793-803. PubMed ID: 10577851
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients.
    Valencak J; Weihsengruber F; Rappersberger K; Trautinger F; Chott A; Streubel B; Muellauer L; Der-Petrossian M; Jonak C; Binder M; Raderer M
    Ann Oncol; 2009 Feb; 20(2):326-30. PubMed ID: 18836086
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monoclonal gammopathy after low-grade MALT lymphoma: evidence for a second neoplasm.
    Pachmann S; Anderegg B; Müller-Höcker J; Nathrath W; Brack N; Tigges FJ; Hartenstein R; Munker R
    Am J Hematol; 2002 Jun; 70(2):167-73. PubMed ID: 12111792
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma.
    Troch M; Woehrer S; Streubel B; Weissel M; Hoffmann M; Müllauer L; Chott A; Raderer M
    Ann Oncol; 2008 Jul; 19(7):1336-1339. PubMed ID: 18334510
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review.
    Wu Y; Zhao L; Chai Y
    Niger J Clin Pract; 2018 Mar; 21(3):392-394. PubMed ID: 29519992
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type.
    Kao SC; Kau HC; Tsai CC; Tsay SH; Yang CF; Wu JS; Hsu WM
    Am J Ophthalmol; 2007 Feb; 143(2):311-316. PubMed ID: 17184716
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
    Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
    J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A case of primary mucosa-associated lymphoid tissue lymphoma of the bladder regressed after rituximab in combination with CHOP chemotherapy].
    Kakuta Y; Katoh T; Saitoh J; Yazawa K; Hosomi M; Itoh K
    Hinyokika Kiyo; 2006 Dec; 52(12):951-4. PubMed ID: 17252980
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): a case report and review of the literature.
    Duman BB; Sahin B; Ergin M; Guvenc B
    Med Oncol; 2012 Jun; 29(2):1223-6. PubMed ID: 21805377
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit.
    Ben Simon GJ; Cheung N; McKelvie P; Fox R; McNab AA
    Ophthalmology; 2006 Jul; 113(7):1209-13. PubMed ID: 16647129
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.
    Davis TA; Grillo-López AJ; White CA; McLaughlin P; Czuczman MS; Link BK; Maloney DG; Weaver RL; Rosenberg J; Levy R
    J Clin Oncol; 2000 Sep; 18(17):3135-43. PubMed ID: 10963642
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features.
    Inagaki H; Chan JK; Ng JW; Okabe M; Yoshino T; Okamoto M; Ogawa H; Matsushita H; Yokose T; Matsuno Y; Nakamura N; Nagasaka T; Ueda R; Eimoto T; Nakamura S
    Am J Pathol; 2002 Apr; 160(4):1435-43. PubMed ID: 11943727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Extranodal marginal zone lymphoma of the ocular adnexa].
    Møller A; Specht L; Toft PB; Sjø LD
    Ugeskr Laeger; 2008 Nov; 170(45):3660-3. PubMed ID: 18986616
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study.
    Zucca E; Conconi A; Laszlo D; López-Guillermo A; Bouabdallah R; Coiffier B; Sebban C; Jardin F; Vitolo U; Morschhauser F; Pileri SA; Copie-Bergman C; Campo E; Jack A; Floriani I; Johnson P; Martelli M; Cavalli F; Martinelli G; Thieblemont C
    J Clin Oncol; 2013 Feb; 31(5):565-72. PubMed ID: 23295789
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.
    Pijpe J; van Imhoff GW; Vissink A; van der Wal JE; Kluin PM; Spijkervet FK; Kallenberg CG; Bootsma H
    Ann Rheum Dis; 2005 Jun; 64(6):958-60. PubMed ID: 15576414
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma.
    Coiffier B; Radford J; Bosly A; Martinelli G; Verhoef G; Barca G; Davies A; Decaudin D; Gallop-Evans E; Padmanabhan-Iyer S; Van Eygen K; Wu KL; Gupta IV; Lin TS; Goldstein N; Jewell RC; Winter P; Lisby S;
    Br J Haematol; 2013 Nov; 163(3):334-42. PubMed ID: 24032456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma.
    Thiede C; Wündisch T; Alpen B; Neubauer B; Morgner A; Schmitz M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A;
    J Clin Oncol; 2001 Mar; 19(6):1600-9. PubMed ID: 11250988
    [TBL] [Abstract][Full Text] [Related]  

  • 79. State-of-the-art therapeutics: marginal-zone lymphoma.
    Bertoni F; Zucca E
    J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease.
    Raderer M; Püspök A; Birkner T; Streubel B; Chott A
    Leuk Lymphoma; 2004 Jul; 45(7):1459-62. PubMed ID: 15359648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.